CARLIE WOODARD: Open Payments
NPI 1720682420 · NEW LEXINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 15 payments from 11 companies in 2025. Trend: 2023 $450 · 2024 $471 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Pulmonx Corporation | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: FARXIGA, QULIPTA, LINZESS, CHARTIS CATHETER, ZENPEP, CAPLYTA, NURTEC ODT, Korlym.
Industry payments across OH — which companies pay providers there.
